Neurology
U.S. Department of Defense Awards $2 Million to Brain Plasticity Inc. to Study Impact of Brain Training for Traumatic Brain Injuries
June 21, 2011 7:45 am | by Bio-Medicine.Org | News | CommentsSAN FRANCISCO, June 21, 2011 /- Brain Plasticity Inc. (BPI), a technology incubator dedicated to the discovery and development of novel technologies that harness the basic principles of brain plasticity to improve the lives of people with neurological and psychiatric disorders, was...
Pilot's Dream Comes True Thanks to New Robotic Surgery
June 20, 2011 9:42 am | by Bio-Medicine.Org | News | CommentsCHICAGO, June 20, 2011 /PRNewswire-USNewswire/ -- Andrew Baniecki dreamed of becoming a pilot for as long as he can remember. His passion for airplanes began when he was a small child opting to play with toy planes instead of cars, and grew when he took his first ride on an airplane...
Neuralstem Updates NSI-189 Major Depression Trial
June 20, 2011 6:45 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md., June 20, 2011 /- Neuralstem, Inc. (NYSE Amex: CUR ) announced that it has been approved to dose the final cohort in the ongoing Phase Ia trial to test the safety of NSI-189 for the treatment of major depression. Phase Ia is testing the drug in healthy volunteers for safety...
Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine
June 17, 2011 11:36 am | by Bio-Medicine.Org | News | CommentsLOS ANGELES, June 17, 2011 /- Damage to the spine can happen for any number of reasons, whether it's a slip or fall, car accident, wear and tear from old age, or blunt injury. Unfortunately, people who have experienced back injury in the past have had to deal with back braces, reduced...
Novartis seeks vaccine approval for infants
June 17, 2011 1:34 am | by Mass High Tech: The Journal of New England Technology | News | CommentsThe U.S. Food and Drug Administration is reviewing a vaccine for invasive meningococcal disease developed by Novartis Vaccines and Diagnostics, the Cambridge division of Switzerland-based Novartis, for accepted use in infants and toddlers from two months to two years old.
Denver School Nurses Unite Community in the Fight against Meningitis, a Potentially Deadly Disease
June 15, 2011 8:36 am | by Bio-Medicine.Org | News | CommentsDENVER, June 15, 2011 /- The Colorado Association of School Nurses (CASN) has joined with the Colorado Department of Public Health and Environment, among other local organizations, on the Denver Voices of Meningitis campaign to help educate parents of preteens and teens about the dangers...
MigreLief Now On Lifetime T.V.'s "The Balancing Act" Airing June 20th & July 25th
June 14, 2011 11:34 am | by Bio-Medicine.Org | News | CommentsLOS ANGELES, June 14, 2011 /- The makers of MigreLief , the world's most successful patented natural migraine prevention therapy, can now be seen on the popular nationally broadcast Lifetime series, " The Balancing Act." On June 20th and again on July 25th, (7:00 a.m. et/pt) this...
ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists
June 14, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsMOUNT LAUREL, N.J., June 14, 2011 /- ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians. ImpactRx now has access to 175 adult...
Reportlinker Adds Middle East And Africa Neurology Devices Market Outlook to 2017
June 9, 2011 3:33 am | by Bio-Medicine.Org | News | CommentsNEW YORK, June 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Middle East And Africa Neurology Devices Market Outlook to 2017...
Vycor Medical, Inc. Completes Equity Capital Raise
June 8, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsBOCA RATON, Fla., June 8, 2011 /- On June 7, 2011, Vycor Medical, Inc. ("Vycor" or the "Company") completed the sale of $1,570,000 in Units comprising Preferred Shares and Warrants (the "Units") to accredited investors (the "Investors"). The Units were issued pursuant to the...
Imaging Method Reveals Hidden Brain Injuries
June 7, 2011 8:32 pm | by Massachusetts Institute of Technology | News | CommentsThe brains of soldiers who have been exposed to blasts show tissue damage up to a year later.
Cancer vaccines come of age with positive clinical data
June 6, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsA new form of treatment that goes beyond oncology drugs and surgery is now coming of age: cancer vaccines. At the American Society of Clinical Oncology meeting in Chicago over the weekend - a major forum for cancer researchers - several companies and research groups reported progress on...
Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
June 2, 2011 7:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md., June 2, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO...
Jazz Pharmaceuticals Announces Presentation at the Jefferies 2011 Global Healthcare Conference in New York on June 8
June 2, 2011 1:33 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif., June 2, 2011 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that the company will make a presentation at the Jefferies 2011 Global Healthcare Conference in New York on Wednesday, June 8, 2011 at 9:30 a.m. Eastern Time. Bruce Cozadd, the company's chairman...
Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
June 1, 2011 4:33 am | by Bio-Medicine.Org | News | CommentsNEW YORK, June 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017...
The Brain Stimulation Headset from Valkee Makes Light Work of Jet Lag, Job Stress and Winter Blues
June 1, 2011 12:34 am | by RealWire | News | CommentsThe Brain Stimulation Headset, Valkee (http://www.valkee.com), substitutes the mood-elevating effects of the sun, by channelling safe bright light directly to photosensitive regions of the brain through the ear canal. Valkee has been proven to increase energy, and can act as a...
MultiCell Technologies is Granted Stem Cell Patent
May 31, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsWOONSOCKET, R.I., May 31, 2011 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver...
Restorative Therapies, Inc., Today Announced a Rehabilitation Breakthrough, the RT600 Functional Electrical Stimulation (FES) Stepper
May 31, 2011 4:33 am | by Bio-Medicine.Org | News | CommentsBALTIMORE, May 31, 2011 /- Restorative Therapies, Inc., advances its new era in physical therapy systems for neurological injury and paralysis with FDA clearance of the world's first Functional Electrical Stimulation (FES) rehabilitation therapy system for stepping and standing. FES is a...
Northwestern Survey Finds FDA Predictability a Top Concern Among Medtech Firms; Europe Preferred for Product Approval
May 24, 2011 9:34 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, May 24, 2011 /- Two-thirds of small medical device and diagnostic companies -- the drivers of innovation in the sector -- are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industry-wide survey...
Images of a Hard-Hitting Disease
May 18, 2011 8:41 pm | by Massachusetts Institute of Technology | News | CommentsAdvanced imaging techniques could help diagnose the degenerative brain disease linked to repetitive head trauma.
Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software
May 18, 2011 11:47 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, May 18, 2011 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said today that it has released version 6.10 of its...
Celldex prices $31.5M stock offering
May 18, 2011 6:42 am | by Mass High Tech: The Journal of New England Technology | News | CommentsCelldex Therapeutics Inc., the Needham company developing a brain cancer vaccine, has priced a public offering of 10 million shares of its common stock at about $3.15 per share. The offering would raise $31.5 million, with Celldex taking in about $29.4 million in net proceeds.
Neurologix Announces First Quarter 2011 Financial Results
May 13, 2011 6:41 am | by Bio-Medicine.Org | News | CommentsFORT LEE, N.J., May 13, 2011 /- Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for disorders of the brain and central nervous system, today announced its financial results for the three months ended March 31, 2011. For the...
United Spinal Association Broadens Its Reach with Users First: Giving Voice to All Wheelchair Users
May 12, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- United Spinal Association has announced the inclusion of Users First as a new program that advocates for improved access to seating and mobility equipment by empowering wheelchair users, clinicians, and providers. (Logo:...
Two Devices Treat Alzheimer's
May 11, 2011 8:34 pm | by Massachusetts Institute of Technology | News | CommentsCompanies hope that brain stimulation will work where drugs have failed.
